You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for PUREVIT DUALFE PLUS CAPSULE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for PUREVIT DUALFE PLUS CAPSULE

Average Pharmacy Cost for PUREVIT DUALFE PLUS CAPSULE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.37748 EACH 2025-01-22
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.38209 EACH 2024-12-18
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.37984 EACH 2024-11-20
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.38875 EACH 2024-10-23
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.37626 EACH 2024-09-18
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.36809 EACH 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for PUREVIT DUALFE PLUS Capsule

Introduction

PUREVIT DUALFE PLUS is a prescription drug designed to treat iron deficiency anemia and folate deficiency, utilizing a unique combination of ferrous fumarate and polysaccharide iron complex. This analysis will delve into the market dynamics, pricing trends, and projections for this medication.

Market Context

The global medicine market is expected to grow at a compound annual growth rate (CAGR) of 3-6% through 2025, reaching a total market size of approximately $1.6 trillion. This growth is influenced by factors such as the adoption of new treatments, patent expiries, and competition from generics and biosimilars[3].

Product Overview

PUREVIT DUALFE PLUS contains 162 mg of ferrous fumarate and 115.2 mg of polysaccharide iron complex, providing a total of 106 mg of elemental iron per capsule. It is indicated for various conditions including iron deficiency anemia, folate deficiency, menorrhagia, pregnancy, and other scenarios where iron and folate supplementation is necessary[1].

Pricing and Cost-Sharing

In the context of health insurance formularies, drugs like PUREVIT DUALFE PLUS are typically categorized based on their cost-sharing tiers. For instance, in the UCare Medicare Group Formulary, generic drugs (which could include iron supplements if available in generic form) often have a $0 copay for preferred generic drugs. However, since PUREVIT DUALFE PLUS is an unapproved drug, its cost-sharing may vary and could fall under non-preferred or specialty drug tiers, which might have higher copays[2].

Price Projections

Given the current trends in the pharmaceutical market, several factors will influence the pricing of PUREVIT DUALFE PLUS:

Generic Competition

The launch of generic versions of similar drugs can significantly impact pricing. For example, the generic version of Vyvanse (lisdexamfetamine) has seen a slower-than-expected market share increase due to manufacturing and supply issues, but it still led to a decrease in average wholesale price (AWP) per claim by 6-17% after the generic launch[4].

Regulatory Changes

Changes in regulatory policies, such as the removal of the Average Manufacturer Price cap (AMP Cap) under the American Rescue Plan Act, can affect commercial drug pricing. This could lead to an overall AWP increase of 13-17% annually among commercial plans from 2023 to 2025[4].

Market Demand and Supply

The demand for iron supplements is steady due to the prevalence of iron deficiency anemia. However, the supply chain and manufacturing efficiencies can impact the pricing. PUREVIT DUALFE PLUS, being an unapproved drug, may face unique challenges in pricing due to its regulatory status.

Projected Price Trends

  • Short-Term Projections: Given the current market dynamics, it is likely that the price of PUREVIT DUALFE PLUS will remain relatively stable in the short term, with potential minor adjustments based on production costs and market competition.
  • Long-Term Projections: Over the next few years, if generic versions of similar iron supplements become more prevalent, the price of PUREVIT DUALFE PLUS could decrease. However, if the drug remains unapproved and faces limited competition, its price might increase due to the lack of generic alternatives and the overall rise in pharmaceutical costs.

Adverse Reactions and Precautions

The pricing and market acceptance of PUREVIT DUALFE PLUS can also be influenced by its side effect profile and precautions. Common gastrointestinal disturbances and the risk of accidental overdose, especially in children, need to be considered by both prescribers and patients, which could impact demand and pricing[1].

Global Market Implications

The global market for medicines is expected to grow, driven by increased healthcare access and the adoption of new treatments. In pharmerging countries, particularly China, there is an anticipated acceleration in the use of new original medicines post-COVID-19. This could lead to increased demand for iron supplements globally, potentially stabilizing or increasing prices for PUREVIT DUALFE PLUS if it gains international approval and market presence[3].

Key Takeaways

  • Market Growth: The global medicine market is expected to grow at a CAGR of 3-6% through 2025.
  • Pricing Factors: Generic competition, regulatory changes, and market demand will significantly influence the pricing of PUREVIT DUALFE PLUS.
  • Regulatory Status: The unapproved status of PUREVIT DUALFE PLUS may affect its pricing and market acceptance.
  • Side Effects and Precautions: The drug's side effect profile and precautions will impact its demand and pricing.

Frequently Asked Questions (FAQs)

Q: What is PUREVIT DUALFE PLUS used for? A: PUREVIT DUALFE PLUS is used to treat iron deficiency anemia and folate deficiency, particularly in conditions such as extended convalescence, menorrhagia, pregnancy, and advanced age[1].

Q: What are the common side effects of PUREVIT DUALFE PLUS? A: Common side effects include gastrointestinal disturbances such as anorexia, nausea, diarrhea, and constipation. These are usually mild and may subside with continuation of therapy[1].

Q: Is PUREVIT DUALFE PLUS approved by the FDA? A: No, PUREVIT DUALFE PLUS has not been found by the FDA to be safe and effective, and its labeling has not been approved by the FDA[1].

Q: How does the pricing of PUREVIT DUALFE PLUS compare to other iron supplements? A: The pricing can vary based on its regulatory status and the presence of generic alternatives. It may fall under higher cost-sharing tiers due to its unapproved status[2].

Q: What are the long-term price projections for PUREVIT DUALFE PLUS? A: Long-term projections suggest that the price could decrease if generic versions become prevalent, but it may increase if the drug remains unapproved and faces limited competition[4].

Cited Sources

  1. DailyMed: PUREVIT DUALFE PLUS- ferrous fumarate, polysaccharide iron complex capsule.
  2. UCare: 2025 UCare Medicare Group Formulary - State of MN.
  3. IQVIA: Global Medicine Spending and Usage Trends: Outlook to 2025.
  4. Milliman: Commercial drug trends: 2024 release.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.